Viscosupplementation Market Growth to Be Boosted by Increasing Osteoarthritis Prevalence

 

Viscosupplementation is a negligibly intrusive method that lessens joint agony and works on the utilitarian state of the osteoarthritic joint. It is a treatment wherein a thick liquid named hyaluronate or hyaluronic corrosive is infused into the knee joint Hyaluronic corrosive is conveyed all through the body in epithelial, connective tissues, and neural tissues to advance better joint turn of events and grease. Osteoarthritis is a sort of joint pain that happens when the adaptable tissue at the closures of bones starts to wear out. Additionally, osteoarthritis is the most well-known type of joint inflammation on the planet. It tends to be arranged into 2 classifications like essential and auxiliary osteoarthritis.

Osteoarthritis is described by loss of capacity and degeneration of ligament and tissues that cover the finishes of the bones in a joint. There is certifiably not a total remedy for osteoarthritis, hyaluronic corrosive is thought to further develop the greasing up properties of the synovial liquid, give a more agreeable degree of action, further develop versatility, and diminish the aggravation from osteoarthritis of the knee. The expanding pervasiveness of osteoarthritis is relied upon to build the interest for viscosupplementation items, which is relied upon to drive the viscosupplementation market development. As per the World Health Organization (WHO), around 9.6% of men and 18.0% of ladies matured 60 years or more have suggestive osteoarthritis around the world. Be that as it may, the number is relied upon to increment because of the developing geriatric populace and the weight pandemic.

Moreover, novel biomimetic polymer viscosupplements are rapidly replacing in-development osteoarthritis joint injections, and thus, key players are focused on increasing research and development in biocompatible polymers. These polymers are widely used in the Food and Drug Administration (FDA) approved stents, surgical meshes, and contact lenses, and help prevent degradation associated with hyaluronate. Furthermore, the viscosupplementation market is expected to witness robust growth in 2021 with a somewhat recovery of emerging and developed economies from the global pandemic (COVID-19).

In terms of geography, the market is divided into six regions, such as North America, Europe, Asia Pacific, South America, the Middle East, and Africa. Osteoarthritis is the most common joint disorder in the United States. The increasing prevalence of lifestyle-induced disorders, increasing demand for non-surgical treatments for osteoarthritis, and technological advances in the development of hyaluronic acid-based therapies are some of the factors expected to foster the viscosupplementation market growth. For instance, in 2019, Anika Therapeutics showcased HYALOFAST, a biodegradable, hyaluronic acid-based scaffold for cartilage repair at the 2019 International Cartilage Regeneration and Joint Preservation Society (ICRS) Focus Meeting.